- Home
- LSTA
as 01-17-2025 4:00pm EST
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.
| Founded: | 1980 | Country: | United States |
| Employees: | N/A | City: | BASKING RIDGE |
| Market Cap: | 31.2M | IPO Year: | N/A |
| Target Price: | $15.00 | AVG Volume (30 days): | 53.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.51 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.19 - $4.20 | Next Earning Date: | 02-27-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Lisata Therapeutics Inc. News
LSTA Breaking Stock News: Dive into LSTA Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
Lisata Therapeutics to Present at the 2025 Sequire Investor Summit
Simply Wall St.
10 days ago
US Penny Stocks To Watch In January 2025
Clinical Trials Arena
a month ago
Lisata completes subject enrolment in multi-cancer trial of certepetide
Exec Edge
a month ago
Lisata Therapeutics Completes Enrollment for Cancer Therapy Trial
GlobeNewswire
a month ago
Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX Trial
Medical Device Network
a month ago
Lisata and Kuva Labs partner for MR imaging agents to detect cancer
MT Newswires
2 months ago
Lisata Therapeutics, Kuva Labs Collaborate on Cancer Diagnostics
GlobeNewswire
2 months ago
Lisata Therapeutics and Kuva Labs Announce Global License Agreement for Solid Tumor Imaging
Compare LSTA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LSTA Lisata Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.